Zhiyang Ling

1.7k total citations
23 papers, 813 citations indexed

About

Zhiyang Ling is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Zhiyang Ling has authored 23 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 7 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in Zhiyang Ling's work include Immune Cell Function and Interaction (7 papers), COVID-19 Clinical Research Studies (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Zhiyang Ling is often cited by papers focused on Immune Cell Function and Interaction (7 papers), COVID-19 Clinical Research Studies (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Zhiyang Ling collaborates with scholars based in China, India and South Korea. Zhiyang Ling's co-authors include Bing Sun, Yaguang Zhang, Xiaoyu Sun, Wangpeng Gu, Chunyan Yi, Zhuo Yang, Longfei Ding, Xiaoxia Lü, Aidong Qu and Jianqing Xu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Zhiyang Ling

20 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhiyang Ling China 13 443 257 162 152 70 23 813
Wangpeng Gu China 10 403 0.9× 291 1.1× 273 1.7× 74 0.5× 45 0.6× 12 910
Jiajia Xie China 12 457 1.0× 314 1.2× 115 0.7× 118 0.8× 39 0.6× 29 862
Kailang Wu China 14 304 0.7× 439 1.7× 145 0.9× 128 0.8× 46 0.7× 20 897
Hannah Limburg Germany 4 570 1.3× 174 0.7× 131 0.8× 119 0.8× 22 0.3× 6 762
Cong Zeng China 16 631 1.4× 285 1.1× 125 0.8× 80 0.5× 27 0.4× 35 928
Cornelius Rohde Germany 7 582 1.3× 165 0.6× 94 0.6× 106 0.7× 26 0.4× 13 740
Oliver Pilgram Germany 7 505 1.1× 182 0.7× 97 0.6× 64 0.4× 23 0.3× 8 696
Javier García‐Pérez Spain 18 372 0.8× 269 1.0× 283 1.7× 129 0.8× 74 1.1× 42 1.1k
Tai‐Ling Chao Taiwan 14 393 0.9× 149 0.6× 83 0.5× 103 0.7× 20 0.3× 41 633

Countries citing papers authored by Zhiyang Ling

Since Specialization
Citations

This map shows the geographic impact of Zhiyang Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiyang Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiyang Ling more than expected).

Fields of papers citing papers by Zhiyang Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiyang Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiyang Ling. The network helps show where Zhiyang Ling may publish in the future.

Co-authorship network of co-authors of Zhiyang Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiyang Ling. A scholar is included among the top collaborators of Zhiyang Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiyang Ling. Zhiyang Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Shipeng, Zhiyang Ling, Xiao Lu, et al.. (2025). TNFR2/CCR8 bispecific antibody enhances antitumor activity through depleting Ti-Tregs and boosting effector CD8 + T cell function. OncoImmunology. 14(1). 2497171–2497171. 1 indexed citations
2.
Wang, Ran, Shipeng Cheng, Xiao Lu, et al.. (2025). Bispecific targeting of 4-1BB and CCR8 boosts antitumor immunity via Ti-Treg depletion and CD8+ activation. iScience. 28(7). 112829–112829.
3.
Lü, Xiaoxia, Zhiao Chen, Chunyan Yi, et al.. (2025). An anti-CD47 antibody binds to a distinct epitope in a novel metal ion-dependent manner to minimize cross-linking of red blood cells. Journal of Biological Chemistry. 301(8). 110420–110420.
4.
Liu, Lian, Danyan Zhang, Rong Fan, et al.. (2024). Serum ECM1 is a promising biomarker for staging and monitoring fibrosis in patients with chronic hepatitis B. Science China Life Sciences. 68(2). 431–440.
5.
Wang, Su, Hua Yin, Songling Zhu, et al.. (2024). MDM2 is essential to maintain the homeostasis of epithelial cells by targeting p53. Journal of Innate Immunity. 16(1). 397–412. 2 indexed citations
6.
Fu, Yadong, Xiaoxi Zhou, Lin Wang, et al.. (2024). Salvianolic acid B attenuates liver fibrosis by targeting Ecm1 and inhibiting hepatocyte ferroptosis. Redox Biology. 69. 103029–103029. 39 indexed citations
7.
Huang, Yuying, Long Xu, Liyan Ma, et al.. (2023). Group 2 innate lymphoid cells boost CD8 + T-cell activation in anti-tumor immune responses. OncoImmunology. 12(1). 2243112–2243112. 6 indexed citations
8.
Zhu, Songling, Kebin Cheng, Lisha Zhang, et al.. (2023). Vitamin B6 regulates IL-33 homeostasis to alleviate type 2 inflammation. Cellular and Molecular Immunology. 20(7). 794–807. 20 indexed citations
9.
Ling, Zhiyang, Chunyan Yi, Xiaoyu Sun, Zhuo Yang, & Bing Sun. (2022). Broad strategies for neutralizing SARS-CoV-2 and other human coronaviruses with monoclonal antibodies. Science China Life Sciences. 66(4). 658–678. 5 indexed citations
10.
Sun, Xiaoyu, Zhiyang Ling, Zhuo Yang, & Bing Sun. (2022). Broad neutralizing antibody-based strategies to tackle influenza. Current Opinion in Virology. 53. 101207–101207. 13 indexed citations
11.
Yi, Chunyan, Xiaoyu Sun, Zhiyang Ling, & Bing Sun. (2022). Jigsaw puzzle of SARS-CoV-2 RBD evolution and immune escape. Cellular and Molecular Immunology. 19(7). 848–851. 7 indexed citations
12.
Yi, Chunyan, Xiaoyu Sun, Chenjian Gu, et al.. (2021). Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants. Genome Medicine. 13(1). 164–164. 43 indexed citations
13.
Zhang, Yaguang, Xiaojing Wang, Xuezhen Li, et al.. (2020). Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients. Cellular and Molecular Immunology. 17(8). 878–880. 45 indexed citations
14.
Lian, Qiaoshi, Shanshan Yan, Qi Yin, et al.. (2020). TRIM34 attenuates colon inflammation and tumorigenesis by sustaining barrier integrity. Cellular and Molecular Immunology. 18(2). 350–362. 27 indexed citations
15.
Zhang, Yaguang, Jin Xu, Ran Jia, et al.. (2020). Protective humoral immunity in SARS-CoV-2 infected pediatric patients. Cellular and Molecular Immunology. 17(7). 768–770. 42 indexed citations
16.
Yi, Chunyan, Xiaoyu Sun, Jing Ye, et al.. (2020). Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cellular and Molecular Immunology. 17(6). 621–630. 329 indexed citations
17.
Wang, Wenshuai, Xiaoyu Sun, Yanbing Li, et al.. (2016). Human antibody 3E1 targets the HA stem region of H1N1 and H5N6 influenza A viruses. Nature Communications. 7(1). 13577–13577. 33 indexed citations
18.
19.
Xu, Ke, Zhiyang Ling, Liang Sun, et al.. (2011). Broad Humoral and Cellular Immunity Elicited by a Bivalent DNA Vaccine Encoding HA and NP Genes from an H5N1 Virus. Viral Immunology. 24(1). 45–56. 38 indexed citations
20.
Bian, Chao, Fang Zhang, Feng Wang, et al.. (2010). Development of retinol-binding protein 4 immunocolloidal gold fast test strip using high-sensitivity monoclonal antibodies generated by DNA immunization. Acta Biochimica et Biophysica Sinica. 42(12). 847–853. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wangpeng Gu Breakdown of academic impact, for papers by Jiajia Xie Breakdown of academic impact, for papers by Kailang Wu Breakdown of academic impact, for papers by Hannah Limburg Breakdown of academic impact, for papers by Cong Zeng Breakdown of academic impact, for papers by Cornelius Rohde Breakdown of academic impact, for papers by Oliver Pilgram Breakdown of academic impact, for papers by Javier García‐Pérez Breakdown of academic impact, for papers by Tai‐Ling Chao
Rankless by CCL
2026